BIOEX Stock Overview
Develops and commercializes a bio-based extraction platform technology.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Bioextrax AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 3.06 |
52 Week High | SEK 4.94 |
52 Week Low | SEK 1.54 |
Beta | 2.7 |
11 Month Change | -14.04% |
3 Month Change | 2.51% |
1 Year Change | -27.49% |
33 Year Change | -91.50% |
5 Year Change | n/a |
Change since IPO | -23.50% |
Recent News & Updates
Recent updates
Shareholder Returns
BIOEX | SE Machinery | SE Market | |
---|---|---|---|
7D | -7.3% | -6.9% | -6.7% |
1Y | -27.5% | 8.9% | 9.9% |
Return vs Industry: BIOEX underperformed the Swedish Machinery industry which returned 8.9% over the past year.
Return vs Market: BIOEX underperformed the Swedish Market which returned 9.9% over the past year.
Price Volatility
BIOEX volatility | |
---|---|
BIOEX Average Weekly Movement | 11.5% |
Machinery Industry Average Movement | 5.4% |
Market Average Movement | 5.9% |
10% most volatile stocks in SE Market | 12.2% |
10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: BIOEX's share price has been volatile over the past 3 months.
Volatility Over Time: BIOEX's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | 13 | Edvard Hall | www.bioextrax.com |
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. It harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids from bacteria. The company was incorporated in 2014 and is based in Lund, Sweden.
Bioextrax AB (publ) Fundamentals Summary
BIOEX fundamental statistics | |
---|---|
Market cap | SEK 105.43m |
Earnings (TTM) | -SEK 22.16m |
Revenue (TTM) | SEK 2.15m |
49.0x
P/S Ratio-4.8x
P/E RatioIs BIOEX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BIOEX income statement (TTM) | |
---|---|
Revenue | SEK 2.15m |
Cost of Revenue | SEK 1.57m |
Gross Profit | SEK 584.00k |
Other Expenses | SEK 22.74m |
Earnings | -SEK 22.16m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.64 |
Gross Margin | 27.12% |
Net Profit Margin | -1,029.12% |
Debt/Equity Ratio | 0% |
How did BIOEX perform over the long term?
See historical performance and comparison